Alessandro Salvi

3.7k total citations
81 papers, 2.6k citations indexed

About

Alessandro Salvi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Alessandro Salvi has authored 81 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 32 papers in Molecular Biology and 28 papers in Cancer Research. Recurrent topics in Alessandro Salvi's work include MicroRNA in disease regulation (18 papers), Viral Infections and Immunology Research (13 papers) and Cardiovascular Effects of Exercise (11 papers). Alessandro Salvi is often cited by papers focused on MicroRNA in disease regulation (18 papers), Viral Infections and Immunology Research (13 papers) and Cardiovascular Effects of Exercise (11 papers). Alessandro Salvi collaborates with scholars based in Italy, United States and Romania. Alessandro Salvi's co-authors include Giuseppina De Petro, F Camerini, Gianfranco Sinagra, Sergio Barlati, Fulvio Camerini, Silvio Klugmann, Nazario Portolani, Ilaria Grossi, Bruno Pinamonti and Mauro Giacca and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Alessandro Salvi

79 papers receiving 2.5k citations

Peers

Alessandro Salvi
Mirjam B. Smeets Netherlands
C Dollery United Kingdom
Mark D. Rekhter United States
Sandra B. Haudek United States
Alessandro Salvi
Citations per year, relative to Alessandro Salvi Alessandro Salvi (= 1×) peers Congcong Zhang

Countries citing papers authored by Alessandro Salvi

Since Specialization
Citations

This map shows the geographic impact of Alessandro Salvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Salvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Salvi more than expected).

Fields of papers citing papers by Alessandro Salvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Salvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Salvi. The network helps show where Alessandro Salvi may publish in the future.

Co-authorship network of co-authors of Alessandro Salvi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Salvi. A scholar is included among the top collaborators of Alessandro Salvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Salvi. Alessandro Salvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pilotto, Andrea, Nicholas J. Ashton, Stefano Gipponi, et al.. (2024). Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease. Journal of Neurology. 271(12). 7537–7546. 16 indexed citations
2.
Zizioli, Daniela, Flora Guerra, Ilaria Grossi, et al.. (2024). miR-23b-3p, miR-126-3p and GAS5 delivered by extracellular vesicles inhibit breast cancer xenografts in zebrafish. Cell Communication and Signaling. 22(1). 552–552. 6 indexed citations
3.
Asperti, Michela, Elisabetta Grillo, Magdalena Gryzik, et al.. (2021). H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis. Free Radical Biology and Medicine. 169. 294–303. 48 indexed citations
4.
Grossi, Ilaria, Annalisa Radeghieri, Lucia Paolini, et al.. (2020). MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study. International Journal of Molecular Medicine. 47(2). 533–546. 67 indexed citations
5.
Milanesi, Elena, Maria Dobre, Vlad Herlea, et al.. (2020). miRNAs‐Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study. Journal of Immunology Research. 2020(1). 4927120–4927120. 21 indexed citations
6.
7.
Stacchiotti, Alessandra, Ilaria Grossi, Alessandro Salvi, et al.. (2019). Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy. Cells. 8(9). 1053–1053. 77 indexed citations
8.
Salvi, Alessandro, et al.. (2017). Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells. International Journal of Oncology. 51(1). 128–144. 23 indexed citations
9.
Danzi, Gian Battista, Luca Olivotti, Renato Valenti, et al.. (2016). Trends of percutaneous coronary intervention in Italy in the last 10 years. Journal of Cardiovascular Medicine. 18(3). 170–177. 7 indexed citations
10.
Berti, Sérgio, Emanuela Piccaluga, Alfredo Marchese, et al.. (2015). Documento di posizione SICI-GISE sugli standard e linee guida per i laboratori di diagnostica e interventistica cardiovascolare. Giornale italiano di cardiologia. 16(10). 590–600. 1 indexed citations
11.
Anzini, Marco, Marco Merlo, Gastone Sabbadini, et al.. (2013). Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis. Circulation. 128(22). 2384–2394. 128 indexed citations
12.
Salvi, Alessandro, Isabel Conde, Bruna Arici, et al.. (2013). Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. Molecular Cancer. 12(1). 162–162. 56 indexed citations
13.
Moimas, Silvia, Serena Zacchigna, Marco Merlo, et al.. (2012). Idiopathic dilated cardiomyopathy and persistent viral infection: Lack of association in a controlled study using a quantitative assay. Heart Lung and Circulation. 21(12). 787–793. 19 indexed citations
14.
Petrelli, Annalisa, Andrea Perra, Katharina Schernhuber, et al.. (2012). Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene. 31(42). 4517–4526. 65 indexed citations
15.
Moncini, Silvia, Alessandro Salvi, Paola Zuccotti, et al.. (2011). The Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular Migration. PLoS ONE. 6(5). e20038–e20038. 83 indexed citations
16.
Salvi, Alessandro, Italia Bongarzone, Francesca Miccichè, et al.. (2009). Proteomic Identification of LASP-1 Down-regulation After RNAi Urokinase Silencing in Human Hepatocellular Carcinoma Cells. Neoplasia. 11(2). 207–IN13. 23 indexed citations
17.
Giacca, Mauro, Giovanni Maria Severini, Luisa Mestroni, et al.. (1994). Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 24(4). 1033–1040. 52 indexed citations
18.
Pinamonti, Bruno, Gianfranco Sinagra, Alessandro Salvi, et al.. (1992). Left ventricular involvement in right ventricular dysplasia. American Heart Journal. 123(3). 711–724. 115 indexed citations
19.
Tanganelli, Piero, Andrea Di Lenarda, Giorgio Bianciardi, et al.. (1989). Correlation between histomorphometric findings on endomyocardial biopsy and clinical findings in idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 64(8). 504–506. 16 indexed citations
20.
Pinamonti, Bruno, et al.. (1988). Echocardiographic findings in myocarditis. The American Journal of Cardiology. 62(4). 285–291. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026